NDC Pharmacologic Class N0000175550 Decreased Immunologic Activity [PE]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0008-1030 | Rapamune | Sirolimus | Solution | Oral | Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. | Human Prescription Drug |
0008-1040 | Rapamune | Sirolimus | Tablet, Sugar Coated | Oral | Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. | Human Prescription Drug |
0008-1041 | Rapamune | Sirolimus | Tablet, Sugar Coated | Oral | Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. | Human Prescription Drug |
0008-1042 | Rapamune | Sirolimus | Tablet, Sugar Coated | Oral | Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. | Human Prescription Drug |
0054-0470 | Everolimus | Everolimus | Tablet | Oral | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0054-0471 | Everolimus | Everolimus | Tablet | Oral | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0054-0472 | Everolimus | Everolimus | Tablet | Oral | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0054-0480 | Everolimus | Everolimus | Tablet | Oral | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0054-0481 | Everolimus | Everolimus | Tablet | Oral | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0054-0497 | Everolimus | Everolimus | Tablet | Oral | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0078-0414 | Zortress | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0415 | Zortress | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0417 | Zortress | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0422 | Zortress | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0566 | Afinitor | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0567 | Afinitor | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0594 | Afinitor | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0620 | Afinitor | Everolimus | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0626 | Afinitor Disperz | Everolimus | Tablet, For Suspension | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0627 | Afinitor Disperz | Everolimus | Tablet, For Suspension | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0628 | Afinitor Disperz | Everolimus | Tablet, For Suspension | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0093-7766 | Everolimus | Everolimus | Tablet | Oral | Teva Pharmaceuticals Usa, Inc. | Human Prescription Drug |
0093-7767 | Everolimus | Everolimus | Tablet | Oral | Teva Pharmaceuticals Usa, Inc. | Human Prescription Drug |
0093-7768 | Everolimus | Everolimus | Tablet | Oral | Teva Pharmaceuticals Usa, Inc. | Human Prescription Drug |
0378-3096 | Everolimus | Everolimus | Tablet | Oral | Mylan Pharmaceuticals Inc. | Human Prescription Drug |
0378-3097 | Everolimus | Everolimus | Tablet | Oral | Mylan Pharmaceuticals Inc. | Human Prescription Drug |
0378-3098 | Everolimus | Everolimus | Tablet | Oral | Mylan Pharmaceuticals Inc. | Human Prescription Drug |
49884-119 | Everolimus | Everolimus | Tablet | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-125 | Everolimus | Everolimus | Tablet | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
49884-127 | Everolimus | Everolimus | Tablet | Oral | Par Pharmaceutical, Inc. | Human Prescription Drug |
50268-718 | Sirolimus | Sirolimus | Tablet | Oral | Avpak | Human Prescription Drug |
55111-653 | Sirolimus | Sirolimus | Tablet | Oral | Dr. Reddy's Laboratories Limited | Human Prescription Drug |
55111-654 | Sirolimus | Sirolimus | Tablet | Oral | Dr. Reddy's Laboratories Limited | Human Prescription Drug |
59762-1001 | Sirolimus | Sirolimus | Tablet, Sugar Coated | Oral | Greenstone Llc | Human Prescription Drug |
59762-1002 | Sirolimus | Sirolimus | Tablet, Sugar Coated | Oral | Greenstone Llc | Human Prescription Drug |
59762-1003 | Sirolimus | Sirolimus | Tablet, Sugar Coated | Oral | Greenstone Llc | Human Prescription Drug |
59762-1205 | Sirolimus | Sirolimus | Solution | Oral | Greenstone Llc | Human Prescription Drug |
60505-6197 | Sirolimus | Sirolimus | Solution | Oral | Apotex Corp | Human Prescription Drug |
65841-771 | Sirolimus | Sirolimus | Tablet, Film Coated | Oral | Cadila Healthcare Limited | Human Prescription Drug |
66689-347 | Sirolimus | Sirolimus | Solution | Oral | Vistapharm, Inc. | Human Prescription Drug |
68084-915 | Sirolimus | Sirolimus | Tablet | Oral | American Health Packaging | Human Prescription Drug |
68382-520 | Sirolimus | Sirolimus | Tablet, Film Coated | Oral | Zydus Pharmaceuticals (usa) Inc. | Human Prescription Drug |
68462-682 | Sirolimus | Sirolimus | Tablet, Film Coated | Oral | Glenmark Pharmaceuticals Inc., Usa | Human Prescription Drug |
68462-683 | Sirolimus | Sirolimus | Tablet, Film Coated | Oral | Glenmark Pharmaceuticals Inc., Usa | Human Prescription Drug |
68462-684 | Sirolimus | Sirolimus | Tablet, Film Coated | Oral | Glenmark Pharmaceuticals Inc., Usa | Human Prescription Drug |
69238-1594 | Sirolimus | Sirolimus | Solution | Oral | Amneal Pharmaceuticals Ny Llc | Human Prescription Drug |
There are 46 NDC products with the pharmacologic class Decreased Immunologic Activity [PE].